| 发明名称 |
CGRP Receptor Antagonists |
| 摘要 |
The disclosures herein relate to novel compounds of formula;;wherein R1, R2 and R3 are as defined herein, and their use in treating, preventing, ameliorating, controlling or reducing cerebrovascular or vascular disorders associated with CGRP receptor function. |
| 申请公布号 |
US2017121331(A1) |
申请公布日期 |
2017.05.04 |
| 申请号 |
US201615336880 |
申请日期 |
2016.10.28 |
| 申请人 |
Heptares Therapeutics Limited |
发明人 |
Christopher John Andrew;Congreve Miles Stuart;Bucknell Sarah Joanne;Deflorian Francesca;Pickworth Mark;Mason Jonathan Stephen |
| 分类号 |
C07D471/10 |
主分类号 |
C07D471/10 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A compound of formula (I)or salts thereof, wherein R1 is R2 is H or forms a spirocyclic heterocyclic ring with R3; R3 forms a spirocyclic heterocyclic ring with R2 or is a heterocyclic ring if R2 is H. |
| 地址 |
Welwyn Garden City GB |
